{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:15:38Z","timestamp":1791915338904,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/gt.2016.57","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T14:40:58Z","timestamp":1468939258000},"page":"775-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations"],"prefix":"10.1038","volume":"23","author":[{"given":"B","family":"Tockner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hainzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Murauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"BFgt201657_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-79271-1","volume-title":"Life with Epidermolysis Bullosa: Etiology, Diagnosis, and Multidisciplinary Care and Therapy","author":"JD Fine","year":"2009","unstructured":"Fine JD, Hintner H (eds). Life with Epidermolysis Bullosa: Etiology, Diagnosis, and Multidisciplinary Care and Therapy. Springer: Wien, Germany and New York, NY, USA, 2009."},{"key":"BFgt201657_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","volume":"70","author":"JD Fine","year":"2014","unstructured":"Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70: 1103\u20131126.","journal-title":"J Am Acad Dermatol"},{"key":"BFgt201657_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.me.44.020193.001201","volume":"44","author":"AN Lin","year":"1993","unstructured":"Lin AN, Carter DM . Epidermolysis bullosa. Annu Rev Med 1993; 44: 189\u2013199.","journal-title":"Annu Rev Med"},{"key":"BFgt201657_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/humu.21651","volume":"33","author":"K Wertheim-Tysarowka","year":"2012","unstructured":"Wertheim-Tysarowka K, Sobczy\u0144ska-Tomaszewska A, Kowalewski C, Skro\u0144ski M, Swi\u0119\u0107kowski G, Kutkowska-Ka\u017amierczak A et al. The COL7A1 mutation database. Hum Mutat 2012; 33: 327\u2013331.","journal-title":"Hum Mutat"},{"key":"BFgt201657_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa0910501","volume":"363","author":"JE Wagner","year":"2010","unstructured":"Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, Woodley DT et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363: 629\u2013639.","journal-title":"N Engl J Med"},{"key":"BFgt201657_CR6","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/jid.2008.78","volume":"128","author":"T Wong","year":"2008","unstructured":"Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008; 128: 2179\u20132189.","journal-title":"J Invest Dermatol"},{"key":"BFgt201657_CR7","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/jid.2015.158","volume":"135","author":"G Petrof","year":"2015","unstructured":"Petrof G, Lwin SM, Martinez-Queipo M, Abdul-Wahab A, Tso S, Mellerio JE et al. Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2015; 135: 2319\u20132321.","journal-title":"J Invest Dermatol"},{"key":"BFgt201657_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/mt.2010.91","volume":"18","author":"M Titeux","year":"2010","unstructured":"Titeux M, Pendaries V, Zanta-Boussif MA, D\u00e9cha A, Pironon N, Tonasso L et al. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 2010; 18: 1509\u20131518.","journal-title":"Mol Ther"},{"key":"BFgt201657_CR9","first-page":"75","volume":"134","author":"Z Siprashvili","year":"2014","unstructured":"Siprashvili Z, Nguyen NT, Gorell E, Khuu P, Furukawa L, Lorenz HP et al. Phase I clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2014; 134: 75.","journal-title":"J Invest Dermatol"},{"key":"BFgt201657_CR10","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/jid.2013.10","volume":"133","author":"DT Woodley","year":"2013","unstructured":"Woodley DT, Wang X, Amir M, Hwang B, Remington J, Hou Y et al. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol 2013; 133: 1910\u20131913.","journal-title":"J Invest Dermatol"},{"key":"BFgt201657_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2302\/kjm.2014-0013-RE","volume":"64","author":"EM Murauer","year":"2015","unstructured":"Murauer EM, Koller U, Pellegrini G, De LM, Bauer JW . Advances in gene\/cell therapy in epidermolysis bullosa. Keio J Med 2015; 64: 21\u201325.","journal-title":"Keio J Med"},{"key":"BFgt201657_CR12","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jid.2012.101","volume":"132","author":"V Wally","year":"2012","unstructured":"Wally V, Murauer EM, Bauer JW . Spliceosome-mediated trans-splicing: the therapeutic cut and paste. J Invest Dermatol 2012; 132: 1959\u20131966.","journal-title":"J Invest Dermatol"},{"key":"BFgt201657_CR13","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1038\/mtna.2014.10","volume":"3","author":"U Koller","year":"2014","unstructured":"Koller U, Wally V, Bauer JW, Murauer EM . Considerations for a successful RNA trans-splicing repair of genetic disorders. Mol Ther Nucleic Acids 2014; 3: e157.","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFgt201657_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/6986","volume":"17","author":"M Puttaraju","year":"1999","unstructured":"Puttaraju M, Jamison SF, Mansfield SG, Garcia-Blanco MA, Mitchell LG . Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat Biotechnol 1999; 17: 246\u2013252.","journal-title":"Nat Biotechnol"},{"key":"BFgt201657_CR15","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","volume":"19","author":"V Wally","year":"2010","unstructured":"Wally V, Brunner M, Lettner T, Wagner M, Koller U, Trost A et al. K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet 2010; 19: 4715\u20134725.","journal-title":"Hum Mol Genet"},{"key":"BFgt201657_CR16","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1038\/mtna.2016.3","volume":"5","author":"P Peking","year":"2016","unstructured":"Peking P, Koller U, Hainzl S, Kocher T, Mayr E, Kitzmueller S et al. Non-viral RNA trans-splicing strategy for in situ treatment of dystrophic epidermolysis bullosa. Mol Ther Nucleic Acids 2016; 5: e287.","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFgt201657_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin U, Kariko K, Tureci O . mRNA-based therapeutics\u2014developing a new class of drugs. Nat Rev Drug Discov 2014; 13: 759\u2013780.","journal-title":"Nat Rev Drug Discov"},{"key":"BFgt201657_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-62703-260-5_2","volume":"969","author":"N Pardi","year":"2013","unstructured":"Pardi N, Muramatsu H, Weissman D, Kariko K . In vitro transcription of long RNA containing modified nucleosides. Methods Mol Biol 2013; 969: 29\u201342.","journal-title":"Methods Mol Biol"},{"key":"BFgt201657_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-1-62703-227-8_30","volume":"961","author":"JW Bauer","year":"2013","unstructured":"Bauer JW, Murauer EM, Wally V, Koller U . RNA trans-splicing for genodermatoses. Methods Mol Biol 2013; 961: 441\u2013455.","journal-title":"Methods Mol Biol"},{"key":"BFgt201657_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hgtb.2012.180","volume":"24","author":"EM Murauer","year":"2013","unstructured":"Murauer EM, Koller U, Hainzl S, Wally V, Bauer JW . A reporter-based screen to identify potent 3' trans-splicing molecules for endogenous RNA repair. Hum Gene Ther Methods 2013; 24: 19\u201327.","journal-title":"Hum Gene Ther Methods"},{"key":"BFgt201657_CR21","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkr465","volume":"39","author":"U Koller","year":"2011","unstructured":"Koller U, Wally V, Mitchell LG, Klausegger A, Murauer EM, Mayr E et al. A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Res 2011; 39: e108.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201657_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/jid.2010.249","volume":"131","author":"EM Murauer","year":"2011","unstructured":"Murauer EM, Gache Y, Gratz IK, Klausegger A, Muss W, Gruber C et al. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. J Invest Dermatol 2011; 131: 74\u201383.","journal-title":"J Invest Dermatol"},{"key":"BFgt201657_CR23","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1038\/mtna.2016.3","volume":"5","author":"P Peking","year":"2016","unstructured":"Peking P, Koller U, Hainzl S, Kitzmueller S, Kocher T, Mayr E et al. A gene gun-mediated nonviral rna trans-splicing strategy for Col7a1 repair. Mol Ther Nucleic Acids 2016; 5: e287.","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFgt201657_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jconrel.2012.04.005","volume":"160","author":"M Pearton","year":"2012","unstructured":"Pearton M, Saller V, Coulman SA, Gateley C, Anstey AV, Zarnitsyn V et al. Microneedle delivery of plasmid DNA to living human skin: formulation coating, skin insertion and gene expression. J Control Rel 2012; 160: 561\u2013569.","journal-title":"J Control Rel"},{"key":"BFgt201657_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nbt0102-47","volume":"20","author":"X Liu","year":"2002","unstructured":"Liu X, Jiang Q, Mansfield SG, Puttaraju M, Zhang Y, Zhou W et al. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 2002; 20: 47\u201352.","journal-title":"Nat Biotechnol"},{"key":"BFgt201657_CR26","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.gt.3301307","volume":"7","author":"SG Mansfield","year":"2000","unstructured":"Mansfield SG, Kole J, Puttaraju M, Yang CC, Garcia-Blanco MA, Cohn JA et al. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Therapy 2000; 7: 1885\u20131895.","journal-title":"Gene Therapy"},{"key":"BFgt201657_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1089\/hum.2005.16.1116","volume":"16","author":"X Liu","year":"2005","unstructured":"Liu X, Luo M, Zhang LN, Yan Z, Zak R, Ding W et al. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells. Hum Gene Ther 2005; 16: 1116\u20131123.","journal-title":"Hum Gene Ther"},{"key":"BFgt201657_CR28","doi-asserted-by":"publisher","first-page":"e3468","DOI":"10.1371\/journal.pone.0003468","volume":"3","author":"TH Coady","year":"2008","unstructured":"Coady TH, Baughan TD, Shababi M, Passini MA, Lorson CL . Development of a single vector system that enhances trans-splicing of SMN2 transcripts. PLoS One 2008; 3: e3468.","journal-title":"PLoS One"},{"key":"BFgt201657_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/sj.mt.6300222","volume":"15","author":"TH Coady","year":"2007","unstructured":"Coady TH, Shababi M, Tullis GE, Lorson CL . Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing. Mol Ther 2007; 15: 1471\u20131478.","journal-title":"Mol Ther"},{"key":"BFgt201657_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1523\/JNEUROSCI.4489-09.2010","volume":"30","author":"TH Coady","year":"2010","unstructured":"Coady TH, Lorson CL . Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy. J Neurosci 2010; 30: 126\u2013130.","journal-title":"J Neurosci"},{"key":"BFgt201657_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nm900","volume":"9","author":"H Chao","year":"2003","unstructured":"Chao H, Mansfield SG, Bartel RC, Hiriyanna S, Mitchell LG, Garcia-Blanco MA et al. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 2003; 9: 1015\u20131019.","journal-title":"Nat Med"},{"key":"BFgt201657_CR32","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/hmg\/ddp264","volume":"18","author":"T Rodriguez-Martin","year":"2009","unstructured":"Rodriguez-Martin T, Anthony K, Garcia-Blanco MA, Mansfield SG, Anderton BH, Gallo JM . Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing. Hum Mol Genet 2009; 18: 3266\u20133273.","journal-title":"Hum Mol Genet"},{"key":"BFgt201657_CR33","doi-asserted-by":"publisher","first-page":"15659","DOI":"10.1073\/pnas.0503150102","volume":"102","author":"T Rodriguez-Martin","year":"2005","unstructured":"Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG, Grover AC, Hutton M, Yu Q et al. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies. Proc Natl Acad Sci USA 2005; 102: 15659\u201315664.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201657_CR34","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","volume":"19","author":"V Wally","year":"2010","unstructured":"Wally V, Brunner M, Lettner T, Wagner M, Koller U, Trost A et al. K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet 2010; 19: 4715\u20134725.","journal-title":"Hum Mol Genet"},{"key":"BFgt201657_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nm1086","volume":"10","author":"M Tahara","year":"2004","unstructured":"Tahara M, Pergolizzi RG, Kobayashi H, Krause A, Luettich K, Lesser ML et al. Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency. Nat Med 2004; 10: 835\u2013841.","journal-title":"Nat Med"},{"key":"BFgt201657_CR36","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/sj.mt.6300178","volume":"15","author":"H Zayed","year":"2007","unstructured":"Zayed H, Xia L, Yerich A, Yant SR, Kay MA, Puttaraju M et al. Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery. Mol Ther 2007; 15: 1273\u20131279.","journal-title":"Mol Ther"},{"key":"BFgt201657_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/gt.2008.150","volume":"16","author":"HY Chen","year":"2009","unstructured":"Chen HY, Kathirvel P, Yee WC, Lai PS . Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing. Gene Therapy 2009; 16: 211\u2013217.","journal-title":"Gene Therapy"},{"key":"BFgt201657_CR38","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.1093\/nar\/gkt621","volume":"41","author":"S Lorain","year":"2013","unstructured":"Lorain S, Peccate C, Le HM, Griffith G, Philippi S, Precigout G et al. Dystrophin rescue by trans-splicing: a strategy for DMD genotypes not eligible for exon skipping approaches. Nucleic Acids Res 2013; 41: 8391\u20138402.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201657_CR39","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/mt.2014.35","volume":"22","author":"F Monjaret","year":"2014","unstructured":"Monjaret F, Bourg N, Suel L, Roudaut C, Le RF, Richard I et al. Cis-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing. Mol Ther 2014; 22: 1176\u20131187.","journal-title":"Mol Ther"},{"key":"BFgt201657_CR40","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/ijms16011179","volume":"16","author":"U Koller","year":"2015","unstructured":"Koller U, Hainzl S, Kocher T, H\u00fcttner C, Klausegger A, Gruber C et al. Trans-splicing improvement by the combined application of antisense strategies. Int J Mol Sci 2015; 16: 1179\u20131191.","journal-title":"Int J Mol Sci"},{"key":"BFgt201657_CR41","first-page":"223","volume-title":"Human Genetic Diseases","author":"V Wally","year":"2011","unstructured":"Wally V, Koller U, Bauer JW. High-throughput screening for highly functional RNA-trans-splicing molecules: correction of plectin in epidermolysis bullosa simplex. In: Plaseska-Karanfilska D (ed). Human Genetic Diseases. InTech Open Access Publisher: Rijeka, Croatia, 2011, pp 223\u2013240."},{"key":"BFgt201657_CR42","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/mt.2010.2","volume":"18","author":"PB Hackett","year":"2010","unstructured":"Hackett PB, Largaespada DA, Cooper LJ . A transposon and transposase system for human application. Mol Ther 2010; 18: 674\u2013683.","journal-title":"Mol Ther"},{"key":"BFgt201657_CR43","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1038\/mtna.2013.61","volume":"2","author":"JB Owens","year":"2013","unstructured":"Owens JB, Mathews J, Davy P, Stoytchev I, Moisyadi S, Allsopp R . Effective targeted gene knockdown in mammalian cells using the piggyBac transposase-based delivery system. Mol Ther Nucleic Acids 2013; 2: e137.","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gt201657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201657","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:34:20Z","timestamp":1684431260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["BFgt201657"],"URL":"https:\/\/doi.org\/10.1038\/gt.2016.57","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]},"assertion":[{"value":"10 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JWB is an inventor on US (US8735366) and European (EP2320952) patent for \u2018Improved pre-mRNA trans-splicing molecules (RTM) and their uses\u2019. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}